GlassScriptPhysician profile
Susan Ann Thomas
NPI 1740569391
$1,481.71
in general payments reported to CMS, 2019-2025
19 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $137 · 2021: $289 · 2022: $374 · 2023: $268 · 2024: $36.04 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.33 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.30 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $136.27 | 2022-2025 | Veozah |
| Mayne Pharma Commercial LLC | $129.75 | 2021-2023 | |
| Scynexis, INC. | $107.27 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.94 | 2019-2025 | |
| Organon LLC | $89.82 | 2021-2023 | Nexplanon |
| Mylan Pharmaceuticals INC. | $89.13 | 2020-2022 | |
| Coopersurgical, INC. | $80.80 | 2019-2021 | |
| Agile Therapeutics, INC. | $36.95 | 2021-2022 | |
| Tris Pharma INC | $36.04 | 2024 | Dyanavel Xr |
| Exeltis, USA INC. | $33.60 | 2021-2022 | |
| Hologic Sales and Service, LLC | $32.77 | 2022-2023 | Aptima |
| Shield Therapeutics INC | $32.65 | 2023 | Accrufer |
| Evofem Biosciences, INC. | $27.45 | 2021-2022 | |
| Duchesnay USA Incorporated | $23.66 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $21.16 | 2023 | Vivify Health Care Team Portal |
| Dysis Medical, INC. | $14.69 | 2023 | Dysis Ultra 2.0, Dysis V3 Digital Coploscope, Dysis View |
| Allergan, INC. | $13.66 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.